Saintlife Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
as on 17-11-2024
- Paid Up Capital ₹ 2.30 M
as on 17-11-2024
- Company Age 8 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 15.00 Cr
as on 17-11-2024
- Satisfied Charges ₹ 3.56 Cr
as on 17-11-2024
- Revenue 12.31%
(FY 2023)
- Profit -34.97%
(FY 2023)
- Ebitda 14.53%
(FY 2023)
- Net Worth 22.01%
(FY 2023)
- Total Assets 18.20%
(FY 2023)
About Saintlife Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 2.30 M.
The company currently has active open charges totaling ₹15.00 Cr. The company has closed loans amounting to ₹3.56 Cr, as per Ministry of Corporate Affairs (MCA) records.
Sanjay Nandwani, Sunil Nandwani, and Yash Nandwani serve as directors at the Company.
- CIN/LLPIN
U24100UR2016PLC007244
- Company No.
007244
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
10 Aug 2016
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Uttarakhand
Industry
Company Details
- Location
Dehradun, Uttarakhand, India
- Telephone
- Email Address
- Social Media-
Who are the key members and board of directors at Saintlife Pharmaceuticals?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sanjay Nandwani  | Director | 04-Oct-2019 | Current |
| Sunil Nandwani | Director | 04-Oct-2019 | Current |
| Yash Nandwani | Director | 25-Oct-2021 | Current |
Financial Performance and Corporate Structure Insights of Saintlife Pharmaceuticals.
Saintlife Pharmaceuticals Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 12.31% increase. The company also saw a substantial fall in profitability, with a 34.97% decrease in profit. The company's net worth Soared by an impressive increase of 22.01%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Saintlife Pharmaceuticals?
In 2023, Saintlife Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Himalaya Meditek Private LimitedActive 25 years 6 monthsSanjay Nandwani and Sunil Nandwani are mutual person
Saintlife Mediscience Private LimitedActive 9 years 9 monthsSanjay Nandwani and Sunil Nandwani are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 25 Nov 2022 | ₹7.00 Cr | Open |
Others Creation Date: 25 Nov 2022 | ₹8.00 Cr | Open |
Others Creation Date: 24 Sep 2020 | ₹6.42 M | Satisfied |
How Many Employees Work at Saintlife Pharmaceuticals?
Unlock and access historical data on people associated with Saintlife Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Saintlife Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Saintlife Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
